BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 21562708)

  • 1. Lobular and non-lobular breast cancers differ regarding axillary lymph node metastasis: a cross-sectional study on 4,292 consecutive patients.
    Vandorpe T; Smeets A; Van Calster B; Van Hoorde K; Leunen K; Amant F; Moerman P; Deraedt K; Brouckaert O; Van Huffel S; Wildiers H; Christiaens MR; Neven P
    Breast Cancer Res Treat; 2011 Jul; 128(2):429-35. PubMed ID: 21562708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of axillary lymph node metastases in patients with T1 breast carcinoma.
    Barth A; Craig PH; Silverstein MJ
    Cancer; 1997 May; 79(10):1918-22. PubMed ID: 9149018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Axillary lymph node status of operable breast cancers by combined steroid receptor and HER-2 status: triple positive tumours are more likely lymph node positive.
    Van Calster B; Vanden Bempt I; Drijkoningen M; Pochet N; Cheng J; Van Huffel S; Hendrickx W; Decock J; Huang HJ; Leunen K; Amant F; Berteloot P; Paridaens R; Wildiers H; Van Limbergen E; Weltens C; Timmerman D; Van Gorp T; Smeets A; Van den Bogaert W; Vergote I; Christiaens MR; Neven P
    Breast Cancer Res Treat; 2009 Jan; 113(1):181-7. PubMed ID: 18264760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors predicting the sentinel and non-sentinel lymph node metastases in breast cancer.
    Ozmen V; Karanlik H; Cabioglu N; Igci A; Kecer M; Asoglu O; Tuzlali S; Mudun A
    Breast Cancer Res Treat; 2006 Jan; 95(1):1-6. PubMed ID: 16322900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of axillary sentinel lymph node detection in the staging of early lobular invasive breast carcinoma: a prospective study.
    Classe JM; Loussouarn D; Campion L; Fiche M; Curtet C; Dravet F; Pioud R; Rousseau C; Resche I; Sagan C
    Cancer; 2004 Mar; 100(5):935-41. PubMed ID: 14983488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting the likelihood of additional nodal metastases in breast carcinoma patients with positive sentinel node biopsy.
    Mustać E; Matusan-Ilijas K; Marijić B; Smokvina M; Jonjić N
    Int J Surg Pathol; 2010 Feb; 18(1):36-41. PubMed ID: 19448065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Axillary lymph node dissection for sentinel lymph node micrometastases may be safely omitted in early-stage breast cancer patients: long-term outcomes of a prospective study.
    Langer I; Guller U; Viehl CT; Moch H; Wight E; Harder F; Oertli D; Zuber M
    Ann Surg Oncol; 2009 Dec; 16(12):3366-74. PubMed ID: 19760047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sentinel lymph node biopsy after neoadjuvant chemotherapy is accurate in breast cancer patients with a clinically negative axillary nodal status at presentation.
    Gimbergues P; Abrial C; Durando X; Le Bouedec G; Cachin F; Penault-Llorca F; Mouret-Reynier MA; Kwiatkowski F; Maublant J; Tchirkov A; Dauplat J
    Ann Surg Oncol; 2008 May; 15(5):1316-21. PubMed ID: 18311507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of additional axillary metastasis of breast cancer following sentinel lymph node surgery.
    Changsri C; Prakash S; Sandweiss L; Bose S
    Breast J; 2004; 10(5):392-7. PubMed ID: 15327491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The incidence and significance of micrometastases in lymph nodes of patients with ductal carcinoma in situ and T1a carcinoma of the breast.
    Broekhuizen LN; Wijsman JH; Peterse JL; Rutgers EJ
    Eur J Surg Oncol; 2006 Jun; 32(5):502-6. PubMed ID: 16569492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of residual breast disease and axillary node involvement for patients who had primary induction chemotherapy for advanced breast cancer.
    Escobar PF; Patrick RJ; Rybicki LA; Hicks D; Weng DE; Crowe JP
    Ann Surg Oncol; 2006 Jun; 13(6):783-7. PubMed ID: 16604475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erratum to: Axillary recurrence rate following negative sentinel node biopsy for invasive breast cancer: long-term follow-up.
    Kiluk JV; Ly QP; Santillan AA; Meade T; Ramos D; Reintgen DS; Dessureault S; Davis M; Shamehdi C; Cox CE
    Ann Surg Oncol; 2010 Feb; 17(2):552-7. PubMed ID: 19957043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary breast cancer phenotypes associated with propensity for central nervous system metastases.
    Tham YL; Sexton K; Kramer R; Hilsenbeck S; Elledge R
    Cancer; 2006 Aug; 107(4):696-704. PubMed ID: 16826579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors that predict the burden of axillary disease in breast cancer patients with a positive sentinel node.
    Beriwal S; Soran A; Kocer B; Wilson JW; Ahrendt GM; Johnson R
    Am J Clin Oncol; 2008 Feb; 31(1):34-8. PubMed ID: 18376225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study of high-nuclear-grade breast cancer in Thailand: subclassification and correlation with prognostic factors and immunohistochemical study.
    Chaiwun B; Nakrungsee S; Sukhamwang N; Srisukho S
    Breast Cancer; 2010; 17(1):35-41. PubMed ID: 19789946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with involvement of four or more axillary nodes for sentinel lymph node-positive patients.
    Katz A; Niemierko A; Gage I; Evans S; Shaffer M; Smith FP; Taghian A; Magnant C
    Int J Radiat Oncol Biol Phys; 2006 May; 65(1):40-4. PubMed ID: 16488555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between genetic and biological aspects in primary non-metastatic breast cancers and corresponding synchronous axillary lymph node metastasis.
    D'Andrea MR; Limiti MR; Bari M; Zambenedetti P; Montagutti A; Ricci F; Pappagallo GL; Sartori D; Vinante O; Mingazzini PL
    Breast Cancer Res Treat; 2007 Mar; 101(3):279-84. PubMed ID: 16835704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinicopathological characteristics and prognostic factors of breast cancer with estrogen- and progesterone-receptor negative and HER-2 overexpression].
    Fan Y; Guan Y; Zhao WH; Li Q; Xu BH
    Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):917-20. PubMed ID: 19173993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sentinel lymph node dissection provides axillary control equal to complete axillary node dissection in breast cancer patients with lobular histology and a negative sentinel node.
    Khakpour N; Hunt KK; Kuerer HM; Yi M; Meric-Bernstam F; Ross MI; Lucci A
    Am J Surg; 2005 Oct; 190(4):598-601. PubMed ID: 16164930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic significance of micrometastases in breast cancer: a SEER population-based analysis.
    Chen SL; Hoehne FM; Giuliano AE
    Ann Surg Oncol; 2007 Dec; 14(12):3378-84. PubMed ID: 17899293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.